When It Comes to Patient Safety, ‘Good Enough’ Is Simply Not | PSQH

By David Goldsteen, CEO of VigiLanz.

In the early 1980s, when I was young in my emergency medicine career, patient safety and risk management were somewhat novel concepts in healthcare. At the time, even hand washing processes went unregimented. Medicine lacked the standardized processes and safety interventions we take for granted today, which often meant that pharmaceutical dosage or interaction errors, hospital-acquired infections, and even surgical injuries were likely common, but generally underappreciated and undocumented—and therefore relatively unnoticed.

Thankfully, that was quite a different world from the one we live in today. In just a few decades—and ushered along by watershed publications such as To Err Is Human—the industry has rallied around the interconnected concepts of patient safety and care quality. This is demonstrated daily within countless specialized checklists and infection control protocols, and reflected on a broader scale by the numerous studies, organizations, and conferences dedicated to safety and quality advancements.

Today, healthcare providers are primed and ready to embrace a culture of safety and quality. Within the last decade, we have seen an increasing movement toward value-based care, more initiatives within hospitals dedicated to patient safety, and more appointments of doctors to the C-suite: a key indicator of increasing recognition that clinical executives must help steer strategic decisions as much as financial, technical, and operations leaders do.

Read more from the original article on Patient Safety & Quality Healthcare.

In Honor of Patient Safety Awareness Week: A Message from Dr. Hayley Burgess

In honor of Patient Safety Awareness Week, I want to take a moment to say thank you. Thank you for the dedication, ingenuity, and compassion you consistently demonstrate as you work every day to keep patients safe.

For more than 20 years, VigiLanz has put patient safety and wellbeing at the heart of everything we do, and we remain committed to providing our pharmacists, infection preventionists, researchers, and safety professionals with the tools and the support you need to make a difference at your hospitals. We are so proud of the work you are doing!

While medical errors remain all too common in the United States, much progress has been made in recent years. It is a privilege to work in an environment that promotes a safe culture – where mistakes can occur and the system can pause to evaluate processes, staffing constraints, and contributing human factors.

However, the startling reality is that many errors go unreported. At VigiLanz, we strive to create technology that not only helps clinical teams anticipate, prevent, and respond to adverse events – but also assists in the documentation and capture of both voluntarily reported and automatically detected safety incidents. Still, we recognize that identifying issues is not enough, and that acting on prevention with this new knowledge is imperative to growing trust from our staff and protecting future patients.

In my previous role, I was a system pharmacy leader. I watched my pharmacists struggle with antiquated reporting and disparate data as they worked to find interventions that could improve patient care. When I discovered VigiLanz, it changed everything! At last, we had standard pharmacy workflow solutions that could assist my team with harm prevention, and finally I had valid data to understand how, when, and where medication management could be improved. I became such a big believer in the innovations that technology can bring when used in synergy with the medical record, and the rest is history.

Today, I have the privilege of leading the operations of the VigiLanz organization, where every day I get to pursue my passion of preventing patient harm and reducing the burden on clinicians. I truly believe that patient safety should be at the heart of every hospital’s innovation strategy, just like it’s at the heart of the VigiLanz mission – and that there’s never been a greater need for advancements in healthcare technology to help us keep our patients safe. It is an honor to do this work and serve you in this way! Thank you for your partnership and your commitment to making a difference, and I look forward to what we can accomplish together.

Hayley Burgess
Chief Operating Officer + Chief Clinical Officer

Why We Believe Patient Safety Should Be At The Heart Of Every Hospital’s Innovation Strategy

A Q&A with David Goldsteen, MD, VigiLanz Chairman and CEO

Even as hospitals make efforts to improve patient safety, adverse events continue to be all too common. A recent study of 11 Boston area hospitals found that such events occurred in nearly one-quarter of all hospital admissions, and of these events, almost one out of every four was preventable.

At VigiLanz, we’ve dedicated more than two decades to improving patient safety and the delivery of quality care inside hospitals. While we know the industry still has a long way to go, we also recognize that many hospitals are prioritizing patient safety improvements like never before, and we’re heartened by how far many of our hospital partners have come.

In this Q&A, David Goldsteen, MD, former Emergency Department physician and VigiLanz’s co-founder and CEO, explores the evolution of patient safety within hospitals over the past two decades. He shares his take on some of the biggest safety improvements that have been made, as well as the steps hospitals can take to create a safer environment for all patients.

You’ve had a front row seat observing patient safety trends over the past few decades. What are some key ways the patient safety landscape has changed?

While preventing adverse events remains a key challenge for all hospitals, I’ve seen many positive developments over the past few years. These include more awareness of safety events among hospital CEOs, and more initiatives dedicated to eradicating them.

In the early 1980s, many hospital CEOs would say that adverse events were not occurring within their organizations. Now, there’s much more recognition that avoidable and preventable safety events are happening—and that they are happening much too frequently.

As this awareness has grown, hospital leaders have made improving patient safety a much higher priority. This shift means that the most innovative hospital leaders are beginning to truly embrace and foster a culture of patient safety.

You mention that some hospitals are beginning to fully embrace a culture of patient safety. What is that and why is it so important?  

While most hospital leaders are moving in this direction, there is still a lot more that many organizations can do to accelerate the momentum. When a hospital fully embraces a culture of safety, three things happen.

One, staff members and physicians are fully encouraged to report safety events. Two, staff and physicians feel comfortable and safe reporting events (they don’t fear retribution). Three, the hospital makes it easy for staff and physicians to report safety events.

When hospitals achieve this state, they have more and faster visibility into the safety events that are occurring, and they can quickly work to prevent similar events from happening in the future. Embracing this culture is essential because it helps hospitals adopt a proactive mentality; it enables them to leverage past experiences to inform predictive algorithms, enabling providers to better anticipate safety events and intervene earlier to improve patient outcomes and prevent injuries across the board.

Safety shouldn’t be a response to an event. Safety should be something that we embrace because there’s risk in everything we do in healthcare, whether it’s taking acetaminophen or going through a complex procedure.”
—David Goldsteen, MD, VigiLanz Chairman and CEO

Let’s explore the third factor you mentioned—that the hospital must make it easy to report safety events. What are some steps hospitals can take to achieve this?

Ensuring staff and physicians have appropriate resources is crucial. An easy-to-use patient safety reporting system that works well with the EHR is essential. This solution should offer anonymous event reporting functionalities. It should also include automated protocols that spur critical next steps once an event has been reported, such as verification, investigation, root cause analysis, and remediation processes. The solution should also enable leadership to monitor and measure key metrics related to event reporting, to ensure they easily identify continuous improvement opportunities.

This is table stakes for any hospital, but the best patient safety software solutions also offer automated event reporting capabilities, which support and expand on human reporting activities by using a robust set of incident detection rules to automatically identify potential safety events.

While we have pursued this capability with vigor at VigiLanz, it is still very new to hospitals. Only about 10 hospitals across the country are actively embracing automated reporting.

This is unfortunate, because it can be a game-changer in patient safety improvements. In a recent survey of 100 hospital leaders by healthcare consultancy Sage Growth Partners, 86% said automated event reporting is “extremely” or “very” crucial to ensuring safety events are identified.

In addition to event reporting solutions, hospitals need tools that assist with real-time identification of potential harm—before it occurs. These include pharmacy, infection prevention and other surveillance tools that integrate with the EHR and the patient safety reporting system. This full-scale and interconnected approach to improving patient safety is no longer a future concept; it’s here and working today. It just needs to be adopted by hospitals.

All hospitals have EHRs, which do have some patient safety functions. Why are additional solutions so important?

EHRs are essential for hospital recordkeeping and have made great strides in enhancing documentation, efficiency, and patient care. However, by nature of what they do, EHRs need to be very rigid databases. Hospitals need other solutions that work alongside EHRs in order to ensure they can be as proactive as possible in preventing safety events. The most effective technology layers on top of the EHR, and enables hospitals to leverage all of the data within it, in real-time, to identify early warning signs and prevent any compromise to patient safety before it begins.

We need to recognize that safety events are always going to be with us—this isn’t something that we can eradicate—but, we can manage it better.
—David Goldsteen, MD, VigiLanz Chairman and CEO

Relying only on the EHR to enhance patient safety is like driving along a steep cliff road without any guard rails for support. There may be heavy signage on the road that alerts you to an upcoming curve, but there’s no additional layer of protection that can prevent a deadly fall.

We’d all be a lot safer if this road had both the signage and the guard rails—just like patients in a hospital would be a lot safer if an EHR and a patient safety reporting system were working in concert to monitor, predict, and intervene.

You’ve mentioned the need for hospitals to ensure staff and physicians have appropriate resources to improve patient safety, but hospitals also are also facing significant financial challenges. How can they balance this against the need to invest in patient safety improvements?

The financial challenges facing hospitals today are very real, but so is the growing threat to patient safety if hospitals do not implement better safety-enhancing solutions. It’s no secret that hospitals are experiencing significant turnover and burnout. Whenever you see that type of tumultuous turnover, safety is naturally going to suffer. But investing in patient safety doesn’t necessarily translate to a long-term financial loss. In fact, it’s just the opposite. Practically speaking, safety events are expensive. Reducing them has a significant ROI. CMS is not reimbursing for errors that lead to prolonged length of stay, for example, and hospitals are experiencing high financial losses due to safety lawsuits and settlements. Hospitals can no longer afford not to invest in safety.

Learn more about how VigiLanz is helping hospitals reduce adverse events and improve patient safety.

VigiLanz Ranked No. 1 by KLAS Research for Pharmacy Surveillance for Sixth Consecutive Year

The patient safety company most trusted by hospitals is recognized as Best in KLAS, totaling 12 KLAS awards in 6 years

MINNEAPOLIS, FEBRUARY 8, 2023 — VigiLanz, a patient safety company, today announced that it has earned the 2023 Best in KLAS designation from KLAS Research for Pharmacy Surveillance.

This is the sixth consecutive year that VigiLanz has been recognized by KLAS as the industry leader in Pharmacy Surveillance, bringing its total count of KLAS awards to 12. These awards span various categories and include Antimicrobial Stewardship, which was folded into the Pharmacy Surveillance award in 2021.

The VigiLanz clinical surveillance platform, which houses the award-winning Pharmacy Surveillance solution, helps clinicians deliver safer, higher quality patient care by converting disparate EHR data into uniform, actionable intelligence.

VigiLanz Pharmacy Surveillance continuously monitors data from the EHR and ancillary clinical systems to improve medication safety, standardize practices, and maximize efficiencies. Based on the system’s built-in rule sets or hospital-specific guidelines, it automatically generates warnings and alerts that help clinicians make appropriate drug therapy decisions.

“VigiLanz Pharmacy Surveillance has been phenomenal. We are able to do a lot more with VigiLanz Pharmacy Surveillance than we could with just the EHR. The solution is easy for the end users. It requires almost no training at all.”

– Manager, June 2022, klasresearch.com


In addition to Pharmacy Surveillance, VigiLanz offers a variety of solutions, including Infection Prevention, Antimicrobial Stewardship, Safety Surveillance, Risk and Claims, Audit, Clinical and Quality Services, and Research. These solutions create an umbrella of protection for hospitals and their patients, facilitating a system-wide approach that provides a crucial and additional layer of safety protection while reducing risks, enhancing patient and staff satisfaction, and streamlining workflows.

“We are extremely proud to receive national recognition from KLAS for the sixth consecutive year,” said VigiLanz Chairman and CEO David Goldsteen, MD. “Our solutions work alongside the EHR to bring hospitals to an even higher level of patient safety, helping to identify and prevent patient safety problems in real-time. We’re deeply grateful for the opportunity to help hospitals create safer systems for their patients, and we’re honored to once again receive overwhelmingly positive reactions regarding our solutions.”

“Best in KLAS” is a recognition given to software and services companies who excel in helping healthcare professionals improve patient care. Rankings are based on thousands of customer surveys from healthcare leaders, administrators, clinicians, and others who interact with the solutions.

Selected commentary collected about VigiLanz Pharmacy Surveillance, January 2023 © 2023 KLAS. Visit klasresearch.com for a complete view.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers and payers to be heard and counted. Working with thousands of healthcare professionals, KLAS gathers insights on software, services and medical equipment to deliver timely reports, trending data and statistical overviews. KLAS data is accurate, honest and impartial. The research directly represents the voice of healthcare professionals and acts as a catalyst for improving vendor performance. To learn more about KLAS and the insights we provide, visit www.KLASresearch.com.

About VigiLanz

Founded in 2001, VigiLanz (www.vigilanzcorp.com) is a privately held, rapidly growing provider of SaaS-based patient safety solutions. The firm is focused on advancing the delivery of quality care by transforming complex patient data into meaningful and actionable alerts in real-time, helping clinicians identify opportunities to reduce risks and improve safety. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, researchers, and other clinicians dedicated to innovative, real-time inpatient care.


For More Information

John Gonda

Q&A: Sharp HealthCare’s Commitment to, and Experience With, Clinical Trials

Five questions for DeAnn Cary, PhD, Director of Research at Sharp HealthCare

Clinical trials are critical to advancing medicine and patient health but participating in them is not easy. Hospitals that serve as clinical trial sites must invest significant time and resources into the process, and one of the most time-consuming elements relates to identifying and enrolling patients in clinical trials.

While many hospitals rely on manual reviews, outdated reports, and other time-consuming methods to find the right candidates, innovative clinical trial sites are turning to new technology that makes the identification and enrollment process much more efficient.

One such organization is Sharp HealthCare, which is using VigiLanz Research to accurately and quickly identify eligible candidates for clinical trial enrollment. In this Q&A, DeAnn Cary, PhD, Director of Research at Sharp HealthCare, discusses the hospital’s approach to clinical trials and why it began using this new technology to support its research efforts.

Tell us about Sharp HealthCare and why it participates in clinical trials?

DC: Sharp HealthCare is a not-for-profit health system based in San Diego that is made up of four acute-care hospitals, three specialty hospitals, three affiliated medical groups, and a full spectrum of other facilities and services.

As a community health system, we firmly believe that it is important to offer cutting edge treatments to our patients. Clinical trials provide opportunities to access the newest treatments (e.g., drugs, devices, or procedures) that would not otherwise be available to them.

How do you choose which clinical trials to participate in and how has your overall participation in trials changed over the past few years? 

DC: When reviewing new trials, we consider several things including our existing portfolio (we typically avoid having competing trials). We also consider whether our patient population is a good fit, as well as whether we have the resources and bandwidth required to meet the requirements and timelines.

We have increased our participation and patient volume in some areas, such as Alzheimer’s. We have decreased our patient volume in other therapeutic areas, such as oncology. Study design and precision medicine has dramatically expanded the inclusion/exclusion criteria making it much harder to find patients who qualify. Precision medicine is definitely better for the patients but more challenging for the teams trying to recruit.

What methods have you historically used to recruit patients?

DC: We advertise for some studies, particularly for those which the sponsor pays for all activities associated with the study. In other therapeutic areas, in which insurance is involved (such as oncology),  it’s more challenging to advertise because not all potential patients have insurance that the clinics accept. In those instances, the recruitment process is highly manual and primarily consists of chart reviews.

How have you improved your clinical trial processes over the years?

DC: The biggest significant improvement in processes has been the use of VigiLanz Research. VigiLanz Research leverages study-specific inclusion and exclusion criteria to automatically review all patients across a hospital network. It screens the entire patient population to identify eligible patients in real time and provides automated alerts and notifications to key team members when there are eligibility matches.

Key benefits of VigiLanz Research include the real-time patient identification for studies that have a very short timeline for identification and recruitment (e.g., cardiac and stroke).

VigiLanz Research has also enabled our small staff of clinical research coordinators to feel confident that they have not missed a single qualified potential research participant. It has also enabled them to focus their time and energies on the patients who meet or nearly meet the study criteria, rather than having to manually review hundreds of patient charts.

“VigiLanz Research has also enabled our small staff of clinical research coordinators to feel confident that they have not missed a single qualified potential research participant.”
—DeAnn Cary, PhD, Director of Research at Sharp HealthCare

Do you believe VigiLanz Research will make Sharp a better candidate for future clinical trials? 

DC: Yes, and we are starting to see some of our sponsor feasibility questionnaires ask if we are using a real-time patient identification platform. As this becomes more common, having a technology like VigiLanz Research will continue to be critical, not only for our success within particular trials, but in our ability to continue participating in trials in general.

Read this case study to learn more about how Sharp is using VigiLanz Research to support clinical trial enrollment.

Related Resources: VigiLanz Research

VigiLanz Announces Launch of New Clinical Trial Patient Identification Solution

VigiLanz Research will help hospitals and clinical research staff increase the number of patients identified for clinical trials, while reducing time and staff effort needed for manual screening

MINNEAPOLIS – October 11, 2022 – VigiLanz, a clinical software surveillance company, has announced the launch of a new solution that will empower researchers to accurately identify more eligible candidates for clinical trial enrollment in near real time. By automating the patient identification process, VigiLanz Research will provide help for clinical trial sites seeking to accelerate patient recruitment, meet time-sensitive enrollment targets, and gain insights on patients screened for eligibility.

Clinical trial screening is often an inefficient, costly, and labor-intensive process for clinical trial sites. More than half of all clinical trials fail to meet their enrollment targets, and nearly a quarter close because of insufficient patient enrollment.

“VigiLanz Research is streamlining the clinical trial recruitment process,” said Dr. David Goldsteen, Chief Executive Officer at VigiLanz, noting that for years clinical research sites have struggled to enroll enough patients. “This new solution leverages our two decades of clinical surveillance expertise into a system that empowers researchers to screen more qualified candidates. For hospitals, this increases the likelihood for clinical trial success, and for sponsors, this potentially saves millions of dollars and helps get products to market faster. Most importantly, it also connects people with opportunities for life-changing treatments that could help them live longer, healthier lives.”

VigiLanz recently partnered with Sharp HealthCare to implement VigiLanz Research for an acute cardiac clinical trial, which has a complex protocol and challenging patient enrollment requirements. VigiLanz Research automated screening processes using data in Sharp’s electronic health record (EHR), vastly increasing the number of patients screened to include all patients in all units, and reducing staff time needed to screen patients by 50%. This not only led to more patients being successfully enrolled in the study, but also improved staff satisfaction by giving them more time to focus on other high-value tasks.

“VigiLanz Research has not only improved our team’s efficiency but also has helped us make a difference in patients’ lives. This solution solved the biggest challenges we had in screening patients for this study – the short enrollment windows. With near real-time updates, we can now identify and enroll subjects who may have otherwise been missed,” said DeAnn Cary, PhD, Director of Research at the Outcomes Research Institute at Sharp HealthCare.

Sharp HealthCare and VigiLanz will be presenting an overview of the research process and the results at the WCG MAGI West 2022 conference in Las Vegas in mid-October. To learn more about VigiLanz Research, visit vigilanzcorp.com/research.



About VigiLanz
Founded in 2001, VigiLanz is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The organization is focused on transforming the delivery of quality care by aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes, and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.


For More Information
John Gonda

VigiLanz Announces Winners of 2022 Vigi Awards

Award winners recognized for optimal and innovative use of clinical surveillance to support and improve patient care

MINNEAPOLIS – Aug. 15, 2022 –VigiLanz, a clinical surveillance company, today announced the winners of the annual Vigi Awards, which honor innovative hospitals throughout the United States.

The Vigi Awards recognize how hospitals have used clinical surveillance to enhance patient safety. The award winners are selected by VigiLanz based on nominations of individuals and teams submitted by VigiLanz customers. All award winners receive a donation to a charity of their choice.

“We are incredibly proud of this year’s Vigi Award winners, and it is our honor to recognize them for their amazing accomplishments and achievements,” said David Goldsteen, MD, VigiLanz CEO. “Demonstrated improvements in patient safety, outcomes, and cost savings matter to us all and it is our privilege to be able to partner with some of our country’s finest hospitals and health systems to improve lives.”

This year’s winners:

Infection Preventionist of the Year:

Adriana Jimenez, PhD, Infection Prevention Manager  – Jackson Health System, Florida
Recognized for using VigiLanz to track isolation and HAI activations, develop device and analysis reports, and customize real-time alerts.

Pharmacy Team of the Year:

Pharmacy Team – Freeman Health System, Missouri
Recognized for using VigiLanz to:

  • Build rules to quickly identify patients discharged with a new cardiology medication so that residents could provide appropriate medication education.
  • Create data mining searches to capture MRSA screens and culture results to validate discontinuation of vancomycin.
  • Identify patients with positive MRSA nasal screens that would benefit from mupirocin.

Safety Team of the Year:

Safety Team – Christus Health, Texas
Recognized for using VigiLanz to improve quality of medication error reports, enable error reporting standardization, and aid in the creation of meaningful action plans.

Rising Star (tie):

Pharmacy Team – Benefis Health System, Montana
Recognized for the development of VigiLanz rules to quickly identify the most severe patients that would likely benefit from a thorough comprehensive medical review, saving staff time.

Rising Star (tie):

Dechen Lama, IT Systems Administrator – Mount Sinai Health System, New York
Recognized for putting infection prevention ideas into action, including quickly creating new rules to identify and isolate COVID-19 and monkeypox patients and enable timely care.

5-Star Patient Care:

Pharmacy and Microbial Stewardship Team – Houston Methodist The Woodlands Hospital, Texas
Recognized for using rule-based alerts in conjunction with a pharmacist-driven MRSA protocol to provide timely de-escalation of antibiotics.


Stewardship Team – Cincinnati Children’s Hospital Medical Center, Ohio
Recognized for enhancing long term health outcomes by using data collected by VigiLanz to identify pediatric patients allergic to Penicillin that may no longer be allergic and would benefit from allergy testing.

They Did What? Wow!:

Laura StinesInfection Prevention Data Analyst – Cone Health System, North Carolina
Recognized for using VigiLanz to automatically populate HAI dashboards, providing more data to drive decision making and analyze trends, and reducing risk of manual entry errors.

Great Catch!:

Continental Division – HCA Healthcare, Colorado
Recognized for using data captured by VigiLanz to investigate care patterns, enable investigations, and catch drug diversions to advance patient safety.

“VigiLanz allows a much more streamlined approach to medication compliance compared to pulling the data from the electronic health record directly. The way VigiLanz collates the information into workable documents means we can also create visual aids, such as graphs and tables, to demonstrate trends or data,” said Holly Monatt, Vice President of Pharmacy Services at HCA Healthcare Continental Division. “The time we spend interpreting and reviewing data is so much more meaningful because of the efficiencies VigiLanz provides us for actual data gathering.”

For more information on the Vigi Awards and award winners, please visit the VigiLanz website.



About VigiLanz
Founded in 2001, VigiLanz is a privately held, rapidly growing provider of SaaS-based clinical surveillance, safety, quality, and risk solutions. The organization is focused on transforming the delivery of quality care by aggregating disparate EHR transactional workflow and documentation data across health systems to identify real-time clinical issues that avoid or minimize harm, optimize clinical outcomes, and support preventive care. VigiLanz is a clinical partner to a large and growing community of hospital CMOs, CMIOs, CIOs, quality and safety teams, infectious disease and control specialists, pharmacists, and other clinicians dedicated to innovative, real-time inpatient care.


For More Information
John Gonda

How One Hospital Successfully Transitioned to a New Patient Safety Reporting System

Learn how Community Health Network, a multi-hospital system serving Central Indiana, underwent a successful transition in patient safety event reporting software in the midst of the pandemic.

Presented in May 2022 by VigiLanz and M. Danielle Dillon, MHL, BSN, RN, CCRN-K, Network Blood Management Director at CHN.

Key webinar learning points:

  • The criteria used to evaluate vendors based on identified problems
  • Lessons and tips for successful implementation, training, and launch processes
  • How the new reporting system positively impacted many areas of the hospital


Transforming hospital safety: How the pandemic is serving as a catalyst for change

Held at the two-year anniversary of the World Health Organization’s declaration of the COVID-19 pandemic, this webinar panel of hospital leaders discussed the challenges they’ve faced in the last two years — as well as the steps they are taking to improve the future of hospital safety for patients, staff and visitors.

The panel of infection preventionists, pharmacists and hospital executives also shared insights from the fourth annual Hospital Patient Safety Report. Based on a January 2022 survey of 100 hospital leaders, the report reveals hospitals’ biggest safety challenges and priorities.

Key webinar learning points:

  • Safety challenges exposed by the pandemic
  • Safety improvements made at the outset of the pandemic that had a long-term impact
  • Leading hospitals’ planned safety improvements and priorities for 2022
  • How hospitals are preparing for future pandemic-like situations


A New Vision For Hospital Safety

a new vision for hospital safety infographic

The Steps Leading Hospitals Are Taking To Overcome The Safety Challenges

What safety challenges are on hospitals’ watch lists, and what are they doing to overcome them? This infographic—featuring insights gathered from VigiLanz’s Hospital Patient Safety Report 2022, Becker’s Hospital Review, JAMA, and more—has answers.